Skip to content
Disclosery

EXANE DERIVATIVES: NOW position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on NOW, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 1,431 NOW shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 1,431 shares
    Change vs previous 13F -16 shares

    0.39% of the 13F portfolio, value $680,397.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 1,447 shares
    Change vs previous 13F +95 shares

    0.23% of the 13F portfolio, value $805,770.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 1,352 shares
    Change vs previous 13F -1,197 shares

    0.21% of the 13F portfolio, value $877,565.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 2,549 shares
    Change vs previous 13F -10 shares

    0.4% of the 13F portfolio, value $1,586,109.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 2,559 shares
    Change vs previous 13F +1,111 shares

    0.34% of the 13F portfolio, value $1,431,293.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,448 shares
    Change vs previous 13F -642 shares

    0.22% of the 13F portfolio, value $724,127.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 2,090 shares
    Change vs previous 13F +69 shares

    0.35% of the 13F portfolio, value $1,150,345.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 2,021 shares
    Change vs previous 13F not available

    0.32% of the 13F portfolio, value $980,131.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).